Mutational profiles of matched parental tumours and corresponding PDOs further recapitulated genetic alterations frequently observed in CRC, noticeably in key driver mutations of CRC, TP53, APC and KRAS (Fig. 3c)44. The gene discussed is TP53; the disease is neoplasm.